Thick, Soft and Gummy - Pharmaceutical Companies Hope to End Pain Pill Abuse with Gooey Pills
A lot of people with serious and chronic pain can’t get the drugs they need because even more people with or without serious and chronic pain abuse narcotic pain killers. Doctors are increasingly hesitant to prescribe appropriately to legitimate pain patients, and with an estimated 6 million Americans abusing prescription drugs at any one time - doctors are in an understandable quandary.
Prescription pain medications are abused by taking more than the recommended dosage, by exceeding the recommended dosage frequency or by taking the medication in ways other than specified. Abusers, for example, might crush and snort a medication intended for time released relief, experiencing all the potency at once - and a considerable high. More simply still, just chewing the tablets can accelerate absorption, and the intensity of the high.
In response to the abuse potential of narcotic type drugs, pharmaceutical companies are testing new formulations less easily manipulated for a quick high. Tablets with active ingredients entombed in a thick and viscous gel are one solution, which consultant Doctor Lynn Webster claims cannot be administered in any way other than their intended manner.
Other formulations in the works include the soft and gummy Remoxy, a test product for Oxycontin, and Embeda, which is a pill-form morphine containing a narcotic antagonist.
Embeda works as promised when patients consume the pill whole, as directed. Should a patient consume, in any way, a broken tablet; the narcotic antagonist gets released - eliminating the effects of the medication.
These new tablet formulations await final FDA approval, before an expected release to market next year.
While critics contend that addicts will find a way to get the high they crave, pain patients are hopeful that with increasing controls on pain med abuse, they will find it easier to get drugs in the quantities they say they need, to keep pain at bay.
Post a comment 0
We welcome republishing of our content on condition that you credit Choose Help and the respective authors. This article is licensed under a Creative Commons License.